[
  {
    "question": "How is HIV diagnosed?",
    "answer": "## HIV Diagnosis\n\nHIV diagnosis is a crucial step in managing the disease and preventing its transmission. The process involves a combination of laboratory tests and clinical evaluations.\n\n### Laboratory Tests for HIV Diagnosis\n\nThere are several laboratory tests used to diagnose HIV:\n\n1. **ELISA (Enzyme-Linked Immunosorbent Assay)**: A screening test that detects the presence of antibodies against HIV in the blood.\n2. **Western Blot**: A confirmatory test that detects the presence of specific antibodies against HIV in the blood.\n3. **p24 Antigen Test**: A test that detects the presence of the p24 protein, which is a component of the HIV virus.\n4. **RNA Tests**: A test that detects the presence of HIV RNA in the blood, which can be used to diagnose HIV in its early stages.\n\n### Clinical Evaluation for HIV Diagnosis\n\nIn addition to laboratory tests, a clinical evaluation is also essential for diagnosing HIV. This includes:\n\n1. **Medical History**: A thorough review of the patient's medical history, including any previous exposure to HIV or symptoms that may be related to the disease.\n2. **Physical Examination**: A physical examination to identify any signs or symptoms that may be related to HIV, such as swollen lymph nodes or skin rashes.\n3. **Risk Assessment**: An assessment of the patient's risk factors for HIV, such as unprotected sex or sharing needles.\n\n### Summary\n\nHIV diagnosis involves a combination of laboratory tests and clinical evaluations. The choice of test depends on the stage of the disease and the patient's symptoms. Early diagnosis and treatment are critical in managing HIV and preventing its transmission.",
    "true_answer": "HIV is diagnosed through HIV testing. There are three types of tests used to diagnose HIV infection: antibody tests, antigen/antibody tests, and nucleic acid tests (NATs). How soon each test can detect HIV infection differs, because each test has a different window period. The window period is the time between when a person may have been exposed to HIV and when a test can accurately detect HIV infection. Window periods for different HIV tests are the followings: Antibody tests can usually detect HIV 23 to 90 days after exposure. Most rapid tests and self-tests are antibody tests. A rapid antigen/antibody test done with blood from a finger stick can usually detect HIV 18 to 90 days after exposure. An antigen/antibody lab test using blood from a vein can usually detect HIV 18 to 45 days after exposure. A NAT can usually detect HIV 10 to 33 days after exposure. When an HIV test is positive, a follow-up test will be conducted for confirmation. Sometimes people will need to visit a health care provider to take a follow-up test using another blood sample. Other times, the follow-up test may be performed in a lab using the original blood sample to ensure that the first positive result wasn\u2019t a false positive"
  },
  {
    "question": "What are the different stages of HIV?",
    "answer": "## Stages of HIV Infection\n\nThe progression of HIV infection is divided into several stages, each with distinct characteristics and clinical manifestations. Understanding these stages is crucial for effective management and treatment of the disease.\n\n### Stages of HIV Infection:\n\n#### 1. **Acute HIV Infection**\n\n- **Duration:** 2-4 weeks\n- **Characteristics:** Acute retroviral syndrome, characterized by flu-like symptoms, rash, and lymphadenopathy\n- **CD4 Count:** Typically >200 cells/\u03bcL\n\n#### 2. **Clinical Latency**\n\n- **Duration:** 8-10 years\n- **Characteristics:** Asymptomatic, with a gradual decline in CD4 count\n- **CD4 Count:** Gradually decreases over time\n\n#### 3. **AIDS-Related Complex (ARC)**\n\n- **Duration:** 2-3 years\n- **Characteristics:** Persistent generalized lymphadenopathy, weight loss, and opportunistic infections\n- **CD4 Count:** <200 cells/\u03bcL\n\n#### 4. **AIDS**\n\n- **Duration:** Variable\n- **Characteristics:** Severe immunosuppression, opportunistic infections, and cancers\n- **CD4 Count:** <200 cells/\u03bcL\n\n#### 5. **End-Stage AIDS**\n\n- **Duration:** Variable\n- **Characteristics:** Severe immunosuppression, opportunistic infections, and multi-organ failure\n- **CD4 Count:** <50 cells/\u03bcL\n\nUnderstanding these stages is essential for effective management and treatment of HIV infection, as well as for preventing transmission to others.",
    "true_answer": "The different stages of HIV are either defined as three: (1) acute HIV infection, (2) chronic HIV infection, and (3) acquired immunodeficiency syndrome (AIDS); or four: (1) acute HIV infection, (2) asymptomatic stage, (3) symptomatic HIV, and (4) Late-stage HIV or AIDS."
  },
  {
    "question": "How is HIV transmitted?",
    "answer": "## HIV Transmission\n\nHIV is transmitted through direct contact with the bodily fluids of an infected person, including:\n\n### Key Bodily Fluids Involved in HIV Transmission\n\n*   **Blood**\n*   **Semen**\n*   **Vaginal secretions**\n*   **Cerebrospinal fluid**\n*   **Synovial fluid**\n*   **Pleural fluid**\n*   **Peritoneal fluid**\n*   **Pericardial fluid**\n*   **Amniotic fluid**\n\n### Modes of HIV Transmission\n\nHIV can be transmitted through various routes, including:\n\n#### **Sexual Transmission**\n\n*   Unprotected sex with an infected person\n*   Sharing needles or syringes contaminated with infected blood\n\n#### **Mother-to-Child Transmission**\n\n*   During pregnancy\n*   During childbirth\n*   Through breastfeeding\n\n#### **Blood Transfusion**\n\n*   Receiving infected blood through a blood transfusion\n\n#### **Sharing Needles**\n\n*   Sharing needles or syringes contaminated with infected blood\n\n#### **Other Routes**\n\n*   HIV can also be transmitted through other bodily fluids, such as saliva, tears, and sweat, although the risk is extremely low.",
    "true_answer": "HIV is spread from the body fluids of an infected person, including blood, breast milk, semen and vaginal fluids. It can also spread from a mother to her baby."
  },
  {
    "question": "What comorbidities are common among people living with HIV?",
    "answer": "## Comorbidities in People Living with HIV\n\n Individuals living with HIV are at an increased risk of developing various comorbidities due to the compromised immune system and the potential side effects of antiretroviral therapy (ART). Understanding these comorbidities is essential for providing comprehensive care and improving the quality of life for people living with HIV.\n\n ### Common Comorbidities:\n These comorbidities can be categorized into several groups, including:\n\n#### 1. Cardiovascular Disease\n\n - **Hypertension**: High blood pressure is a common comorbidity among people living with HIV, often due to the use of certain antiretroviral medications.\n - **Dyslipidemia**: Abnormal lipid profiles can increase the risk of cardiovascular disease in people living with HIV.\n\n#### 2. Metabolic Disorders\n\n - **Diabetes**: People living with HIV are at a higher risk of developing diabetes, particularly those taking certain antiretroviral medications.\n - **Nonalcoholic Fatty Liver Disease (NAFLD)**: NAFLD is a common comorbidity among people living with HIV, often associated with obesity and insulin resistance.\n\n#### 3. Bone Health\n\n - **Osteoporosis**: People living with HIV are at an increased risk of osteoporosis, particularly those taking certain antiretroviral medications.\n - **Fractures**: The risk of fractures is higher among people living with HIV, often due to osteoporosis and other bone-related comorbidities.\n\n#### 4. Neurological Disorders\n\n - **Neurocognitive Disorders**: People living with HIV are at a higher risk of developing neurocognitive disorders, including HIV-associated neurocognitive disorder (HAND).\n - **Mood Disorders**: Depression and anxiety are common comorbidities among people living with HIV, often associated with the psychological burden of living with a chronic illness.\n\n#### 5. Substance Use Disorders\n\n - **Substance Use Disorders**: People living with HIV are at a higher risk of developing substance use disorders, including alcohol and drug use.\n\n#### 6. Cancer\n\n - **Cancer**: People living with HIV are at an increased risk of developing certain types of cancer, including non-Hodgkin lymphoma and Kaposi's sarcoma.\n\n#### 7. Renal Disease\n\n - **Renal Disease**: People living with HIV are at a higher risk of developing renal disease, including chronic kidney disease and kidney failure.\n\n### Summary:\n People living with HIV are at an increased risk of developing various comorbidities, including cardiovascular disease, metabolic disorders, bone health issues, neurological disorders, substance use disorders, cancer, and renal disease. Early detection and management of these comorbidities are essential for improving the quality of life and reducing the risk of complications in people living with HIV.",
    "true_answer": "The most common comorbidities amongst patients with HIV include: diabetes mellitus, cardiovascular disease (CVD, e.g. hypertension), respiratory diseases (e.g. chronic obstructive pulmonary diseases and pneumonia), and hepatic diseases (hepatitis B and C). Liver disease, renal disease, substance dependence and abuse, sexually transmitted infections (herpes simplex, syphilis, gonorrhoea and Mycoplasma genitalium) and psychiatric disorders (including depression, anxiety, schizophrenia and cognitive impairment) are also greater among HIV-positive individuals."
  },
  {
    "question": "How can HIV be prevented?",
    "answer": "## Prevention of HIV Infection\n\nHIV can be prevented through the following measures:\n\n### Safe Sex Practices\n\n- **Condom Use**: Using condoms during sexual intercourse can significantly reduce the risk of HIV transmission.\n- **Sexual Abstinence**: Abstaining from sexual activity is the most effective way to prevent HIV infection.\n\n### Needle Safety\n\n- **Sterile Needles**: Using sterile needles and equipment can prevent HIV transmission through needle sharing.\n- **Safe Injection Practices**: Ensuring safe injection practices can reduce the risk of HIV transmission.\n\n### Blood and Organ Donation\n\n- **Screening Blood and Organ Donations**: Screening blood and organ donations for HIV can prevent the transmission of the virus through transfusions and transplants.\n\n### Antiretroviral Therapy (ART)\n\n- **ART for Pregnant Women**: Administering ART to pregnant women with HIV can prevent mother-to-child transmission of the virus.\n- **ART for Infected Individuals**: ART can reduce the viral load of infected individuals, making them less likely to transmit the virus to others.",
    "true_answer": "HIV prevention involves several key strategies. To reduce the risk of getting HIV, it is important to use condoms correctly every time during sex. For individuals who inject drugs, avoiding drug use altogether is recommended, but if drugs are used, only sterile injection equipment and water should be used, and equipment should never be shared with others. Pre-exposure prophylaxis (PrEP) is an option for those at risk of HIV, involving either a daily HIV medicine or an injectable HIV medicine every two months to lower the risk of infection through sex or injection drug use. For those already living with HIV, taking antiretroviral therapy (ART) as prescribed can reduce the amount of HIV in the blood to undetectable levels, preventing transmission to sexual partners. To prevent perinatal transmission, individuals with HIV who take HIV medicine as prescribed throughout pregnancy and childbirth reduce the risk of passing HIV to their baby to less than 1%. Additionally, in cases where one partner has HIV, PrEP can help protect both the individual and their baby while trying to conceive, during pregnancy, or while breastfeeding."
  },
  {
    "question": "How frequently ART must be taken?",
    "answer": "## Frequency of Antiretroviral Therapy (ART) Administration\n\n Antiretroviral therapy (ART) is a crucial treatment for individuals living with HIV. The frequency of ART administration plays a vital role in maintaining viral suppression and preventing the development of drug resistance.\n\n ### Factors Influencing ART Frequency:\n - **Type of Medication**: Different antiretroviral medications have varying dosing schedules.\n - **Regimen Complexity**: Combination regimens may require more frequent dosing than single-tablet regimens.\n - **Patient Adherence**: Adherence to treatment is essential for the success of ART.\n\n ### ART Frequency:\n - **Most ART Regimens**: Taken once or twice daily.\n - **Some Combination Regimens**: May require more frequent dosing, such as three times a day.\n - **Single-Tablet Regimens**: Often taken once daily.\n\n ### Importance of Adherence:\n - **Viral Suppression**: Consistent ART administration is necessary for maintaining viral suppression.\n - **Prevention of Drug Resistance**: Adherence to treatment helps prevent the development of drug-resistant HIV strains.\n - **Improved Health Outcomes**: Regular ART administration is associated with improved health outcomes and quality of life.",
    "true_answer": "Antiretroviral therapy (ART) must be taken as a pill every day or as a shot once every month or two months."
  },
  {
    "question": "How can we prevent Perinatal transmission of HIV?",
    "answer": "## Prevention of Perinatal Transmission of HIV\n\n### Overview\n\nPreventing perinatal transmission of HIV is crucial to ensure the health and well-being of newborns. This can be achieved through a combination of antiretroviral therapy and safe delivery practices.\n\n### Antiretroviral Therapy (ART)\n\n#### Benefits\n\n*   Reduces the risk of HIV transmission from mother to child\n*   Improves the health of the mother and the newborn\n\n#### Administration\n\n*   **Pregnant Women**: Start ART as soon as possible after diagnosis\n*   **Newborns**: Administer ART within the first 12 hours of life\n*   **Breastfeeding**: Continue ART throughout breastfeeding to prevent transmission\n\n### Safe Delivery Practices\n\n#### Elective Cesarean Delivery\n\n*   **Indications**: Scheduled for women with HIV viral loads > 1000 copies/mL\n*   **Benefits**: Reduces the risk of HIV transmission during delivery\n\n### Additional Measures\n\n#### Antiretroviral Prophylaxis\n\n*   **Benefits**: Reduces the risk of HIV transmission during delivery\n*   **Administration**: Administered to the mother during labor and to the newborn after birth\n\n#### Avoidance of Breastfeeding\n\n*   **Indications**: For women with HIV in the United States\n*   **Benefits**: Reduces the risk of HIV transmission through breast milk\n\n### Summary\n\nPreventing perinatal transmission of HIV requires a comprehensive approach, including antiretroviral therapy, safe delivery practices, and additional measures such as antiretroviral prophylaxis and avoidance of breastfeeding.",
    "true_answer": "To prevent perinatal transmission of HIV, pregnant women should take antiretroviral therapy (ART) throughout pregnancy and childbirth. ART throughout pregnancy and childbirth reduces the chances of perinatal transmission of HIV to less than 1%."
  },
  {
    "question": "What are the main cell types infected with HIV?",
    "answer": "## HIV Infection and Cell Types\n\n HIV primarily targets and infects specific cell types in the human body, leading to the progression of the disease. Understanding the main cell types infected with HIV is crucial for developing effective treatments and prevention strategies.\n\n ### Key Cell Types Infected with HIV:\n \n HIV primarily infects cells that play a crucial role in the immune system. The main cell types infected with HIV include:\n\n ### 1. CD4 T Lymphocytes (Helper T Cells)\n - CD4 T lymphocytes are a type of immune cell that helps coordinate the immune response.\n - HIV infects and destroys these cells, leading to a weakened immune system.\n\n ### 2. Monocytes/Macrophages\n - Monocytes and macrophages are immune cells that engulf and digest foreign particles and cellular debris.\n - HIV infects these cells, allowing the virus to spread and replicate within the body.\n\n ### 3. Microglial Cells\n - Microglial cells are a type of glial cell in the brain and spinal cord that play a role in immune surveillance and neuroinflammation.\n - HIV infects microglial cells, contributing to the development of neurological complications associated with HIV infection.\n\n ### 4. Astrocytes\n - Astrocytes are a type of glial cell in the brain and spinal cord that provide support and nutrients to neurons.\n - HIV infects astrocytes, leading to the disruption of normal brain function and contributing to the development of neurological complications.\n\n ### 5. Neurons\n - Neurons are specialized cells in the brain and spinal cord that transmit and process information.\n - HIV infects neurons, leading to the development of neurological complications associated with HIV infection.\n\n ### 6. Epithelial Cells\n - Epithelial cells form the lining of various organs and tissues, including the skin, respiratory tract, and gastrointestinal tract.\n - HIV infects epithelial cells, allowing the virus to enter the body and spread to other cells.\n\n ### 7. Dendritic Cells\n - Dendritic cells are immune cells that play a key role in the initiation of the immune response.\n - HIV infects dendritic cells, allowing the virus to spread and replicate within the body.\n\n ### 8. Langerhans Cells\n - Langerhans cells are a type of dendritic cell found in the skin and mucous membranes.\n - HIV infects Langerhans cells, allowing the virus to enter the body and spread to other cells.\n\n Understanding the main cell types infected with HIV is essential for developing effective treatments and prevention strategies for HIV infection.",
    "true_answer": "The main cell types found to be infected with HIV are CD4+ T lymphocytes and macrophage-lineage cells."
  },
  {
    "question": "What is the difference between HIV and AIDS?",
    "answer": "HIV (Human Immunodeficiency Virus) is a virus that attacks the immune system and can lead to AIDS (Acquired Immunodeficiency Syndrome). AIDS is a condition that occurs when the immune system is severely weakened and the body is unable to fight off infections and diseases. HIV is the virus that causes AIDS, but not everyone with HIV will develop AIDS. With proper treatment, people with HIV can live long and healthy lives without developing AIDS.",
    "true_answer": "HIV stands for human immunodeficiency virus, which is the virus that causes HIV infection. AIDS stands for acquired immunodeficiency syndrome, the most advanced stage of HIV infection."
  },
  {
    "question": "How is HIV not transmitted?",
    "answer": "## Modes of HIV Transmission and Prevention\n\n### Transmission Methods\n\nHIV can be transmitted through:\n\n*   **Sexual Contact**: Engaging in unprotected sex with an infected individual\n*   **Blood Transfusion**: Receiving blood from an infected donor\n*   **Sharing Needles**: Sharing needles or syringes with an infected person\n*   **Mother-to-Child Transmission**: During pregnancy, childbirth, or breastfeeding\n\n### Prevention Methods\n\nTo prevent HIV transmission, follow these guidelines:\n\n*   **Use Condoms**: Practice safe sex by using condoms during intercourse\n*   **Get Tested**: Regularly test for HIV to know your status\n*   **Avoid Sharing Needles**: Refrain from sharing needles or syringes with others\n*   **Safe Blood Transfusions**: Ensure that blood donations are screened for HIV before transfusion\n\n### Ineffective Prevention Methods\n\nThe following methods are **not** effective in preventing HIV transmission:\n\n*   **Mosquito Bites**: HIV cannot be transmitted through mosquito bites\n*   **Kissing**: HIV is not transmitted through kissing\n*   **Casual Contact**: HIV is not spread through casual contact, such as hugging or shaking hands\n*   **Food or Water**: HIV cannot be transmitted through food or water\n*   **Toilets**: HIV is not spread through contact with toilets or other surfaces",
    "true_answer": "You cannot get HIV from: Air or water. Saliva, tears, sweat, feces, or urine that is not mixed with the blood of a person with HIV. Casual contact with a person who has HIV, such as a handshake, a hug, or a closed-mouth kiss. Contact with objects, such as toilet seats, doorknobs, or dishes used by a person who has HIV. Mosquitoes, ticks, or other biting insects. Other sexual activities that do not involve the exchange of body fluids (for example, touching). HIV can\u2019t be passed through healthy, unbroken skin."
  },
  {
    "question": "What is known about the switch that occurs between patients with latent HIV and active infection?",
    "answer": "## Switch from Latent HIV to Active Infection\n\n### Overview\n\nThe switch from latent HIV to active infection is a complex process involving multiple factors. However, research suggests that the primary trigger for this switch is the reactivation of the virus from latency.\n\n### Key Factors\n\n1. **HIV Reactivation**: The reactivation of HIV from latency is the primary trigger for the switch from latent to active infection.\n2. **Immune System Suppression**: Suppression of the immune system, often due to antiretroviral therapy (ART) failure or non-adherence, can lead to the reactivation of HIV.\n3. **Genetic Factors**: Genetic mutations in the HIV virus or the host genome can influence the switch from latent to active infection.\n4. **Environmental Factors**: Environmental factors, such as stress, can also contribute to the switch from latent to active infection.\n\n### Summary\n\nThe switch from latent HIV to active infection is a multifactorial process, with HIV reactivation being the primary trigger. Understanding these factors is crucial for developing effective strategies to prevent and manage HIV infection.",
    "true_answer": "The switch between latent and active HIV infection is primarily driven by the activation of HIV provirus within latently infected cells. Latent HIV infection occurs when the virus integrates its genetic material into the host cell's DNA, allowing the virus to persist in a dormant state. In latent infection, viral replication and gene expression are minimal or absent, and the infected cells remain functionally normal. This form of infection is responsible for the long-term persistence of HIV in individuals, even when systemic viral replication is suppressed with antiretroviral therapy (ART). The switch to active HIV infection occurs when the provirus becomes transcriptionally active; this is often triggered by extracellular signals or events that activate the host cell . One possible mechanism for the switch involves the binding of cellular transcription factors, such as nuclear factor kappa B (NF-\u03baB) and nuclear factor of activated T-cells (NFAT), to the HIV long terminal repeat (LTR) region, resulting in the activation of proviral transcription. Other factors that can contribute to the switch include cytokines, chemokines, and cellular activation signals. This transition between latent and active HIV infection plays a critical role in the pathogenesis of the disease, as it is during periods of active infection that the virus replicates and spreads to new cells, ultimately leading to the progressive decline of the host immune system . Understanding the molecular mechanisms involved in the switch from latent to active HIV infection could help inform the development of novel therapeutic strategies aimed at targeting and eliminating latently infected cells, which represent a major obstacle to achieving a cure for HIV."
  }
]